ACS Medicinal Chemistry Letters · 2016 · 15 citations · 22 references
PharmacyMedicinal ChemistryPharmacologyDrug DesignDrug DiscoveryLead OptimizationG Protein-coupled Receptor SignalingLigand BindingLigand-based DesignPotency OptimizationProtein-ligand DockingReceptor PharmacologyAgonist ActivityG Protein-coupled Receptor Structure-function RelationshipsProstacyclin AnalogsProstaglandin AnaloguesProstaglandin PharmacologyReceptorsStructural HybridizationSubtype Discovery
To identify G protein-biased and highly subtype-selective EP2 receptor agonists, a series of bicyclic prostaglandin analogues were designed and synthesized. Structural hybridization of EP2/4 dual agonist 5 and prostacyclin analogue 6, followed by simplification of the ω chain enabled us to discover novel EP2 agonists with a unique prostacyclin-like scaffold. Further optimization of the ω chain was performed to improve EP2 agonist activity and subtype selectivity. Phenoxy derivative 18a showed potent agonist activity and excellent subtype selectivity. Furthermore, a series of compounds were identified as G protein-biased EP2 receptor agonists. These are the first examples of biased ligands of prostanoid receptors.
22
Quantifying Ligand Bias at Seven-Transmembrane Receptors
Sudarshan Rajagopal, Seungkirl Ahn, David H. Rominger et al. · Molecular Pharmacology · 2011 · 390 citations
Jonathan D. Violin, Scott M. DeWire, Dennis S. Yamashita et al. · Journal of Pharmacology and Experimental Therapeutics · 2010 · 370 citations
Medicine, Cardiology, Pharmacology +17
Neuroprotective Function of the PGE<sub>2</sub>EP2 Receptor in Cerebral Ischemia
Louise D. McCullough, Liejun Wu, Norman J. Haughey et al. · Journal of Neuroscience · 2004 · 358 citations · Full text
Medicine, Neurobiology, Pharmacology +16
Xiaotao Chen, Philip Pitis, Guodong Liu et al. · Journal of Medicinal Chemistry · 2013 · 203 citations · Full text